Concentric remodeling was associated with an increased risk of developing HFpEF (HR 2.15; 95% CI 1.51-2.99) and mortality, with proteomic analysis revealing inflammatory pathway activation in women.
Cohort (n=60,593)
Yes
Concentric left ventricular remodeling and heart failure with preserved ejection fraction (HFpEF) (n=60,593)
Concentric remodeling vs No concentric remodeling
HFpEF development — HR 2.15 (1.51-2.99)
Effect estimate: HR 2.15 (95% CI 1.51-2.99)
BACKGROUND: Concentric remodeling (cRM) can precede heart failure with preserved ejection fraction (HFpEF), a condition prevalent in women. METHODS: Patients (n=60 593, 54.2% women) visiting outpatient clinics of Cardiology Centers of the Netherlands were analyzed for cRM, HFpEF development, and mortality risk. We studied risk factors for relative wall thickness both sex-stratified and in women and men combined. Biomarker profiling was performed (4534 plasma proteins) in a substudy involving 557 patients (65.4% women) to identify pathways involved in cRM. RESULTS: cRM was present in 23.5% of women and 27.6% of men and associated with developing HFpEF (HR, 2.15 95% CI, 1.51-2.99) and mortality risk (HR, 1.09 95% CI, 1.00-1.19) in both sexes. Age, heart rate, and hypertension were statistically significantly stronger risk factors for relative wall thickness in women than men. Higher circulating levels of IFNA5 (interferon alpha-5) were associated with higher relative wall thickness in women only. Pathway analysis revealed differential pathway activation by sex and increased expression of inflammatory pathways in women. CONCLUSIONS: cRM is prevalent in approximately 1 in 4 women and men visiting outpatient cardiology clinics and associated with HFpEF development and mortality risk in both sexes. Known risk factors for cRM were more strongly associated in women than men. Proteomic analysis revealed inflammatory pathway activation in women, with a central role for IFNA5. Differential biologic pathway activation by sex in cRM may contribute to the female predominance of HFpEF and holds promise for identification of new therapeutic avenues for prevention and treatment of HFpEF. REGISTRATION: URL: https://www. CLINICALTRIALS: gov; Unique identifier: NCT001747.
Building similarity graph...
Analyzing shared references across papers
Loading...
Anne Margje Lisa Naomi van Ommen
University Medical Center Utrecht
Ernest Diez Benavente
General Cardiology
N. Charlotte Onland‐Moret
Utrecht University
Circulation Heart Failure
Washington University in St. Louis
Utrecht University
University Medical Center Utrecht
Building similarity graph...
Analyzing shared references across papers
Loading...
Ommen et al. (Thu,) conducted a cohort in Concentric left ventricular remodeling and heart failure with preserved ejection fraction (HFpEF) (n=60,593). Concentric remodeling vs. No concentric remodeling was evaluated on HFpEF development (HR 2.15, 95% CI 1.51-2.99). Concentric remodeling was associated with an increased risk of developing HFpEF (HR 2.15; 95% CI 1.51-2.99) and mortality, with proteomic analysis revealing inflammatory pathway activation in women.
synapsesocial.com/papers/6a154cb3b2e0231f15823f99 — DOI: https://doi.org/10.1161/circheartfailure.122.010255
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: